Group One Trading
IPCI

Group One Trading’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Group One Trading’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-700
Closed -$15K – 5403
2017
Q2 		$15K Sell
700
-100
-13% -$2.1K ﹤0.01% 4066
2017
Q1 		$20K Buy
800
+310
+63% +$7.99K ﹤0.01% 3882
2016
Q4 		$14K Buy
+490
New +$13.7K ﹤0.01% 3858
2016
Q1 		– Sell
-1,000
Closed -$20K – 5223
2015
Q4 		$20K Hold
1,000
– – ﹤0.01% 3919
2015
Q3 		$18K Buy
+1,000
New +$26.3K ﹤0.01% 4092
2015
Q2 		– Sell
-2,100
Closed -$59K – 5368
2015
Q1 		$59K Buy
+2,100
New +$51K ﹤0.01% 3271
2014
Q4 		– Sell
-3,610
Closed -$109K – 5503
2014
Q3 		$109K Sell
3,610
-2,620
-42% -$75.5K ﹤0.01% 2903
2014
Q2 		$237K Sell
6,230
-250
-4% -$9.63K ﹤0.01% 2248
2014
Q1 		$285K Buy
6,480
+5,900
+1,017% +$236K ﹤0.01% 2147
2013
Q4 		$21K Buy
+580
New +$15.6K ﹤0.01% 4213

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading's IPCI Position: Q2 2018 in Review

Group One Trading sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2018, closing a stake of 733 shares — an estimated $4K sold.

Group One Trading first reported a position in IPCI in Q1 2014 and held it in 10 quarters. The position peaked at $47K in Q1 2014. 24 funds tracked by Wall St. Rank hold IPCI as of Q2 2018.

  • Group One Trading reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2018 after selling out during the quarter.
  • Group One Trading sold 733 Intellipharmaceuticals International Inc. shares in Q2 2018, an estimated $4K.
  • Group One Trading first reported a position in Intellipharmaceuticals International Inc. in Q1 2014 and held it in 10 quarters.
  • Group One Trading's Intellipharmaceuticals International Inc. position peaked at $47K in Q1 2014.
  • 24 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.